In this study, we found that the creatinine/cystatin C ratio can effectively stratify the prognosis of CRC patients with the same level of pathological staging, suggesting that the creatinine/cystatin C ratio can be a useful supplement in predicting the prognosis of CRC patients. Here, CST3 is linked to colorectal carcinoma.